V

Veru
D

VERU

1.04500
USD
-0.04
(-3.24%)
مغلق
حجم التداول
117,200
الربح لكل سهم
-0
العائد الربحي
-
P/E
-4
حجم السوق
152,971,196
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
الأخبار
المقالات

العنوان: Veru

القطاع: Healthcare
الصناعة: Biotechnology
Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). The company is also in the late-stage development of certain drugs for the management of breast and prostate cancers. It also has a sexual health program that includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in a single segment and generates revenue from the USA which is the key revenue generating market, Brazil, and other regions.